Skip to content

Ultrasonic features of renal damage in hyperuricemia and establishment of evaluation criteria for early renal damage

Ultrasonic features of hyperuricemia and its relationship with joint destruction, and establishment of criteria for early assessment of renal damage

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052817
Enrollment
Unknown
Registered
2021-11-05
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypeluricemia

Interventions

Control group:No

Sponsors

Huadong Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. Meet the internationally accepted diagnostic criteria for gout and hyperuricemia: fasting blood uric acid > 420 umol/L (7 mg/dL) twice on different days after stopping high-purine, high-protein diet for 2 weeks or stopping uric acid-lowering drugs for 2 weeks; 3. Voluntarily participate in this study and comply with the study regulations, understand and comply with the follow-up plan, and voluntarily sign a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with hyperuricemia caused by secondary factors, such as leukemia, myeloma, renal failure, polycystic kidney disease, certain endocrine diseases, metabolic acidosis, hyperuricemia caused by certain drugs (such as diuretics, aspirin, anti-tuberculosis drugs, etc.); hereditary hyperuricemia; 2. Severe cardiopulmonary and liver dysfunction; 3. Patients with urinary tract infection, renal tubulointerstitial disease, peritoneal dialysis, hemodialysis and renal transplantation; 4. Pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
Ultrasound examination;Dual energy CT(Computed Tomography);Urine routine;Blood routine;Liver function;Kidney function;

Countries

China

Contacts

Public ContactDiao Xuehong

Huadong Hospital Affiliated to Fudan University

xuehong_d@126.com+86 13262905089

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026